Kura Oncology, Inc.
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
315 employees · est. 2014 · San Diego, United States
Probmet Therapeutics
An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients.
2 employees · est. 2022 · Denmark
Kura Oncology, Inc. is the older company (2014 vs 2022); Kura Oncology, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Kura Oncology, Inc. | Probmet Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2022 |
| Headquarters | ||
| Headquarters | San Diego, United States | Denmark |
| Employees | ||
| Employees | 315 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Convertible Note |
| Total Funding | ||
| Total Funding | $1.17B | $500.00K |
| Funding Rounds | ||
| Funding Rounds | 12 | 1 |
| Services | ||
| Services | Development of novel cancer therapeutics, Precision medicine research, Investigation of drug combinations | Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy |
| Target Customers | ||
| Target Customers | Patients with cancer, Caregivers, Healthcare providers, Investors | Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Biopharmaceuticals, Oncology, Cancer Therapeutics, Menin Inhibition, Farnesyl Transferase Inhibition, Treatment Resistance, Relapsed Acute Myeloid Leukemia, NPM1 Mutation, Smart Combination Regimens, Compound Development, Pharmaceutical Commercialization, Cancer Biology, Oral Oncology Drugs, Targeted Cancer Therapies | Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals |
| Website | ||
| Website | kuraoncology.com | probmet.com |
About Kura Oncology, Inc.
Kura Oncology, Inc., founded in 2014 and headquartered in the United States, is a leading player in the Biotechnology and Pharmaceutical sectors. The company is committed to its mission: "Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer li...
About Probmet Therapeutics
Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission r...
We will tell you when either one moves
BounceWatch watches Kura Oncology, Inc. and Probmet Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kura Oncology, Inc. and Probmet Therapeutics — by email.
Frequently Asked Questions
Compare Kura Oncology, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kura Oncology, Inc. on 10 Jun 2026, and Probmet Therapeutics on 14 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
